Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 17 (KRT18P17) is a member of a large set of processed pseudogenes derived from the keratin 18 gene, which is part of the type II keratin gene family. Processed pseudogenes like KRT18P17 are DNA sequences that resemble functional genes but lack the ability to code for proteins due to accumulated mutations and the absence of required regulatory elements. The majority of keratin 18 pseudogenes arose through retrotransposition and are dispersed throughout the human genome, but they do not have a coding or regulatory function and are not included among functional cellular targets[1][3][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 17 (KRT18P17).